Glaukos Net Income 2014-2025 | GKOS
Glaukos annual/quarterly net income history and growth rate from 2014 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Glaukos net income for the quarter ending March 31, 2025 was $-0.018B, a 55.57% decline year-over-year.
- Glaukos net income for the twelve months ending March 31, 2025 was $-0.124B, a 12.2% decline year-over-year.
- Glaukos annual net income for 2024 was $-0.146B, a 8.7% increase from 2023.
- Glaukos annual net income for 2023 was $-0.135B, a 35.75% increase from 2022.
- Glaukos annual net income for 2022 was $-0.099B, a 100.02% increase from 2021.
| Glaukos Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-146 |
| 2023 | $-135 |
| 2022 | $-99 |
| 2021 | $-50 |
| 2020 | $-120 |
| 2019 | $15 |
| 2018 | $-13 |
| 2017 | $0 |
| 2016 | $5 |
| 2015 | $-37 |
| 2014 | $-12 |
| 2013 | $-13 |
| Glaukos Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-18 |
| 2024-12-31 | $-34 |
| 2024-09-30 | $-21 |
| 2024-06-30 | $-51 |
| 2024-03-31 | $-41 |
| 2023-12-31 | $-37 |
| 2023-09-30 | $-30 |
| 2023-06-30 | $-33 |
| 2023-03-31 | $-35 |
| 2022-12-31 | $-31 |
| 2022-09-30 | $-28 |
| 2022-06-30 | $-46 |
| 2022-03-31 | $5 |
| 2021-12-31 | $-22 |
| 2021-09-30 | $6 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-16 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-16 |
| 2020-06-30 | $-40 |
| 2020-03-31 | $-54 |
| 2019-12-31 | $37 |
| 2019-09-30 | $-14 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $2 |
| 2018-09-30 | $-7 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $1 |
| 2017-09-30 | $1 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $1 |
| 2016-12-31 | $0 |
| 2016-09-30 | $1 |
| 2016-06-30 | $2 |
| 2016-03-31 | $1 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-32 |
| 2015-03-31 | $-1 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-4 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.408B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $188.582B | 82.60 |
| Thermo Fisher Scientific (TMO) | United States | $154.218B | 18.65 |
| Edwards Lifesciences (EW) | United States | $44.793B | 29.37 |
| Alcon (ALC) | Switzerland | $43.149B | 29.16 |
| IDEXX Laboratories (IDXX) | United States | $41.707B | 47.93 |
| DexCom (DXCM) | United States | $33.596B | 51.93 |
| IQVIA Holdings (IQV) | United States | $26.668B | 14.94 |
| Mettler-Toledo (MTD) | United States | $24.844B | 29.55 |
| STERIS (STE) | Ireland | $23.875B | 26.30 |
| Waters (WAT) | United States | $20.729B | 29.25 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.648B | 0.00 |
| Hologic (HOLX) | United States | $14.389B | 15.63 |
| Sysmex ADR (SSMXY) | Japan | $10.323B | 29.29 |
| Penumbra (PEN) | United States | $9.933B | 77.96 |
| Masimo (MASI) | United States | $9.319B | 34.38 |
| Globus Medical (GMED) | United States | $8.169B | 19.47 |
| Teleflex (TFX) | United States | $5.447B | 8.99 |
| TransMedics (TMDX) | United States | $4.715B | 102.50 |
| Integer Holdings (ITGR) | United States | $4.259B | 22.31 |
| PROCEPT BioRobotics (PRCT) | United States | $3.478B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.525B | 15.03 |
| Nihon Kohden (NHNKY) | Japan | $2.253B | 25.84 |
| Veracyte (VCYT) | United States | $2.181B | 30.60 |
| Elekta AB (EKTAY) | Sweden | $2.013B | 18.10 |
| Alphatec Holdings (ATEC) | United States | $1.742B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.246B | 116.76 |
| Pulse Biosciences (PLSE) | United States | $1.163B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.079B | 5.74 |
| Beta Bionics (BBNX) | United States | $0.842B | 0.00 |
| SiBone (SIBN) | United States | $0.804B | 0.00 |
| IRadimed (IRMD) | United States | $0.773B | 39.23 |
| RxSight (RXST) | United States | $0.622B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.09 |
| Mesa Laboratories (MLAB) | United States | $0.561B | 13.15 |
| Delcath Systems (DCTH) | United States | $0.555B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.523B | 0.00 |
| AxoGen (AXGN) | United States | $0.474B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| NeuroPace (NPCE) | United States | $0.424B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.379B | 10.09 |
| ClearPoint Neuro (CLPT) | United States | $0.373B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.371B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| 908 Devices (MASS) | United States | $0.250B | 0.00 |
| Neuronetics (STIM) | United States | $0.245B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.41 |
| Alpha Tau Medical (DRTS) | Israel | $0.220B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.172B | 0.00 |
| CVRx (CVRX) | United States | $0.162B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Accuray (ARAY) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.118B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 50.00 |
| EnVVeno Medical (NVNO) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.031B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.36 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |